Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2

Increased intestinal permeability (IP) has emerged recently as a common underlying mechanism in the pathogenesis of allergic, inflammatory, and autoimmune diseases. The characterization of zonulin, the only physiological mediator known to regulate IP reversibly, has remained elusive. Through proteom...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 106; no. 39; pp. 16799 - 16804
Main Authors Tripathi, Amit, Lammers, Karen M, Goldblum, Simeon, Shea-Donohue, Terez, Netzel-Arnett, Sarah, Buzza, Marguerite S, Antalis, Toni M, Vogel, Stefanie N, Zhao, Aiping, Yang, Shiqi, Arrietta, Marie-Claire, Meddings, Jon B, Fasano, Alessio
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 29.09.2009
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Increased intestinal permeability (IP) has emerged recently as a common underlying mechanism in the pathogenesis of allergic, inflammatory, and autoimmune diseases. The characterization of zonulin, the only physiological mediator known to regulate IP reversibly, has remained elusive. Through proteomic analysis of human sera, we have now identified human zonulin as the precursor for haptoglobin-2 (pre-HP2). Although mature HP is known to scavenge free hemoglobin (Hb) to inhibit its oxidative activity, no function has ever been ascribed to its uncleaved precursor form. We found that the single-chain zonulin contains an EGF-like motif that leads to transactivation of EGF receptor (EGFR) via proteinase-activated receptor 2 (PAR₂) activation. Activation of these 2 receptors was coupled to increased IP. The siRNA-induced silencing of PAR₂ or the use of PAR₂⁻/⁻ mice prevented loss of barrier integrity. Proteolytic cleavage of zonulin into its α₂- and β-subunits neutralized its ability to both activate EGFR and increase IP. Quantitative gene expression revealed that zonulin is overexpressed in the intestinal mucosa of subjects with celiac disease. To our knowledge, this is the initial example of a molecule that exerts a biological activity in its precursor form that is distinct from the function of its mature form. Our results therefore characterize zonulin as a previously undescribed ligand that engages a key signalosome involved in the pathogenesis of human immune-mediated diseases that can be targeted for therapeutic interventions.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
Communicated by Maria Iandolo New, Mount Sinai School of Medicine, New York, NY, June 25, 2009
Author contributions: S.G., T.S.-D., T.M.A., S.N.V., M.-C.A., J.B.M., and A.F. designed research; A.T., K.M.L., S.N.-A., M.S.B., A.Z., S.Y., M.-C.A., and A.F. performed research; S.N.-A., M.S.B., and A.F. contributed new reagents/analytic tools; A.T., K.M.L., S.G., T.S.-D., S.N.-A., M.S.B., T.M.A., S.N.V., A.Z., S.Y., M.-C.A., J.B.M., and A.F. analyzed data; and S.G., T.S.-D., T.M.A., S.N.V., J.B.M., and A.F. wrote the paper.
ISSN:0027-8424
1091-6490
1091-6490
DOI:10.1073/pnas.0906773106